-
Patent Agency Ranking
公开(公告)号：US20160200738A1
公开(公告)日：2016-07-14
申请号：US14995791
申请日：2016-01-14
Applicant: Salix Pharmaceuticals, Ltd
Inventor： Karen S. Gushurst , Donglai Yang , Petinka Vlahova , Jeffrey S. Stults
IPC: C07D498/22
CPC classification number: C07D498/22 , C07D498/12
Abstract: The present invention relates to Rifaximin polymorphic forms, to their use in medicinal preparations and to therapeutic methods using them.
Abstract translation: 本发明涉及利福昔明多晶型物，其用于药物制剂和使用它们的治疗方法。
-
公开(公告)号：US09700545B2
公开(公告)日：2017-07-11
申请号：US15141099
申请日：2016-04-28
Applicant: Salix Pharmaceuticals, Ltd
Inventor： Karen S. Gushurst , Donglai Yang , Melanie Janelle Bevill , Nathan Carl Schultheiss , Giuseppe Claudio Viscomi
IPC: A61K31/437 , C07D498/16 , C07D498/18 , C07D471/22
CPC classification number: A61K31/437 , C07D471/22 , C07D498/16 , C07D498/18
Abstract: The present invention relates to Rifaximin amorphous forms, to their use in medicinal preparations and to therapeutic methods using them.
-
公开(公告)号：US09546183B2
公开(公告)日：2017-01-17
申请号：US14995791
申请日：2016-01-14
Applicant: Salix Pharmaceuticals, Ltd
Inventor： Karen S. Gushurst , Donglai Yang , Petinka Vlahova , Jeffrey S. Stults
IPC: C07D498/22 , C07D498/12
CPC classification number: C07D498/22 , C07D498/12
Abstract: The present invention relates to Rifaximin polymorphic forms, to their use in medicinal preparations and to therapeutic methods using them.
Abstract translation: 本发明涉及利福昔明多晶型物，其用于药物制剂和使用它们的治疗方法。
-
公开(公告)号：US20160317507A1
公开(公告)日：2016-11-03
申请号：US15141099
申请日：2016-04-28
Applicant: Salix Pharmaceuticals, Ltd
Inventor： Karen S. Gushurst , Donglai Yang , Melanie Janelle Bevill , Nathan Carl Schultheiss , Giuseppe Claudio Viscomi
IPC: A61K31/437
CPC classification number: A61K31/437 , C07D471/22 , C07D498/16 , C07D498/18
Abstract: The present invention relates to Rifaximin amorphous forms, to their use in medicinal preparations and to therapeutic methods using them.
-
公开(公告)号：US09273066B2
公开(公告)日：2016-03-01
申请号：US14062333
申请日：2013-10-24
Applicant: Salix Pharmaceuticals, Ltd
Inventor： Karen S. Gushurst , Donglai Yang , Petinka Vlahova , Jeffrey S. Stults
IPC: C07D498/22 , C07D498/12
CPC classification number: C07D498/22 , C07D498/12
Abstract: The present invention relates to Rifaximin polymorphic forms, to their use in medicinal preparations and to therapeutic methods using them.
-
-
-
-
Search Results
5
records
(took 0.019 seconds)
